These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 34894606

  • 1. Integrative bioinformatics analysis the clinical value of KMT5A in different subtypes of lung cancer.
    Liu S, Tian W, Li B.
    Comput Biol Chem; 2022 Feb; 96():107603. PubMed ID: 34894606
    [Abstract] [Full Text] [Related]

  • 2. System analysis of FHIT in LUAD and LUSC: The expression, prognosis, gene regulation network, and regulation targets.
    Situ Y, Gao R, Lei L, Deng L, Xu Q, Shao Z.
    Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
    [Abstract] [Full Text] [Related]

  • 3. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
    Xu XL, Gong Y, Zhao DP.
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
    [Abstract] [Full Text] [Related]

  • 4. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
    Fu L, Wang H, Wei D, Wang B, Zhang C, Zhu T, Ma Z, Li Z, Wu Y, Yu G.
    PLoS One; 2020 Dec; 15(5):e0233283. PubMed ID: 32437446
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. High KRT8 Expression Independently Predicts Poor Prognosis for Lung Adenocarcinoma Patients.
    Xie L, Dang Y, Guo J, Sun X, Xie T, Zhang L, Yan Z, Amin H, Guo X.
    Genes (Basel); 2019 Jan 10; 10(1):. PubMed ID: 30634629
    [Abstract] [Full Text] [Related]

  • 7. The Effect of GLUT1 on the Survival Rate and Immune Cell Infiltration of Lung Adenocarcinoma and Squamous Cell Carcinoma: A Meta and Bioinformatics Analysis.
    Zhang G, Dong R, Kong D, Liu B, Zha Y, Luo M.
    Anticancer Agents Med Chem; 2022 Jan 10; 22(2):223-238. PubMed ID: 34238200
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
    Gan BL, He RQ, Zhang Y, Wei DM, Hu XH, Chen G.
    Int J Oncol; 2018 Oct 10; 53(4):1557-1579. PubMed ID: 30066858
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q, Wang Z, Zhang M, Yu Y, Chen R, Lu T, Liu L, Ma J, Liu T, Zheng H, Li H, Li J.
    BMC Cancer; 2021 Nov 13; 21(1):1216. PubMed ID: 34774014
    [Abstract] [Full Text] [Related]

  • 10. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
    Yang Y, Wang M, Liu B.
    J Cell Physiol; 2019 Apr 13; 234(4):4454-4459. PubMed ID: 30317601
    [Abstract] [Full Text] [Related]

  • 11. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
    Zhou S, Wang P, Su X, Chen J, Chen H, Yang H, Fang A, Xie L, Yao Y, Yang J.
    PLoS One; 2017 Apr 13; 12(10):e0187356. PubMed ID: 29088286
    [Abstract] [Full Text] [Related]

  • 12. GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma.
    Ning J, Jiang S, Li X, Wang Y, Deng X, Zhang Z, He L, Wang D, Jiang Y.
    BMC Pulm Med; 2021 Jun 10; 21(1):199. PubMed ID: 34112123
    [Abstract] [Full Text] [Related]

  • 13. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N, Li Y, Zheng P, Zhan X.
    Front Endocrinol (Lausanne); 2021 Jun 10; 12():755805. PubMed ID: 34745015
    [Abstract] [Full Text] [Related]

  • 14. Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma.
    Koh YW, Han JH, Haam S, Lee HW.
    Anticancer Res; 2024 May 10; 44(5):2081-2089. PubMed ID: 38677736
    [Abstract] [Full Text] [Related]

  • 15. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
    Liu X, Chen L, Zhang T.
    Cancer Control; 2018 May 10; 25(1):1073274818778001. PubMed ID: 29843532
    [Abstract] [Full Text] [Related]

  • 16. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development.
    Wei R, Wang Z, Zhang Y, Wang B, Shen N, E L, Li X, Shang L, Shang Y, Yan W, Zhang X, Ma W, Wang C.
    BMC Med Genomics; 2020 Aug 14; 13(1):112. PubMed ID: 32795325
    [Abstract] [Full Text] [Related]

  • 17. Differential prognostic impact and potential molecular mechanisms of PCDHGA12 expression in lung adenocarcinoma and squamous cell carcinoma.
    Xu X, Zhang J, Yao T, Zhao X, Wu Q, Lu C, Guo X, Xie S, Qiu L, Bi R, Xue H.
    Int Immunopharmacol; 2024 Sep 30; 139():112727. PubMed ID: 39067405
    [Abstract] [Full Text] [Related]

  • 18. LDHA upregulation independently predicts poor survival in lung adenocarcinoma, but not in lung squamous cell carcinoma.
    Yu C, Hou L, Cui H, Zhang L, Tan X, Leng X, Li Y.
    Future Oncol; 2018 Oct 30; 14(24):2483-2492. PubMed ID: 29756998
    [Abstract] [Full Text] [Related]

  • 19. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma.
    Chen A, Ding S, Shen X, Lin X.
    Comput Math Methods Med; 2021 Oct 30; 2021():9932088. PubMed ID: 34367321
    [Abstract] [Full Text] [Related]

  • 20. LINC00628 is differentially expressed between lung adenocarcinoma and squamous cell carcinoma and is associated with the prognosis of NSCLC.
    Liu T, Xu S, Liu X.
    Oncol Lett; 2022 Feb 30; 23(2):55. PubMed ID: 34992687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.